<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02618668</url>
  </required_header>
  <id_info>
    <org_study_id>Momen01098983009</org_study_id>
    <nct_id>NCT02618668</nct_id>
  </id_info>
  <brief_title>Haemodynamic Stability of Ketamine/Propofol Admixture &quot;Ketofol&quot; in Patient Undergoing Endoscopic Retrograde Cholangio Pancreatography</brief_title>
  <acronym>Assiutu</acronym>
  <official_title>Haemodynamic Stability of Ketamine / Propofol Admixture &quot;Ketofol&quot; in Patient Undergoing Endoscopic Retrograde Cholangio Pancreatography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <brief_summary>
    <textblock>
      The investigators aim to evaluate the effect of Ketamine/Propofol Admixture on hemodynamic
      stability, recovery time ,patient &amp; doctor satisfaction scores during Endoscopic Retrograde
      Cholangiopancreatography.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>mean arterial blood pressure from baseline of patient undergoing Endoscopic Retrograde Cholangio pancreatography</measure>
    <time_frame>every 5 minutes up to 30minutes</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>saturation of oxygen from baseline of undergoing Endoscopic Retrograde Cholangio pancreatography</measure>
    <time_frame>every 5 minutes up to 30 minutes</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Heart rate( beat/minute) from baseline of patient</measure>
    <time_frame>every 5 minutes up to 30 minutes</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Recovery score of patient</measure>
    <time_frame>up to 10 minutes after the end of procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>patient and doctor satisfaction score</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Pancreatitis</condition>
  <condition>Cholangitis</condition>
  <arm_group>
    <arm_group_label>Ketamine / Propofol Admixture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ketamine / Propofol Admixture: I.V propofol-ketamine 3:1 mixture(%1 15 ml propofol + 1 ml 50mg/ml ketamine+ 4 ml saline in a 20-ml syringe which resulted in 0.25 mg.ml-1 ketamine and 0.75 mg.ml-1 propofol.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>I.V propofol 2 mg/kg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine / Propofol Admixture</intervention_name>
    <description>propofol-ketamine 3:1 mixture(%1 15 ml propofol + 1 ml 50mg/ml ketamine+4 ml saline in a 20-ml syringe which resulted in0.25 mg.ml-1 ketamine and 0.75 mg.ml-1 propofol</description>
    <arm_group_label>Ketamine / Propofol Admixture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>2 mg/kg I.V</description>
    <arm_group_label>Propofol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists ( I ,II )

        Exclusion Criteria:

          1. Presence of liver and/or kidney failure, neuropsychiatric disorders, morbid obesity.

          2. History of substance abuse or dependence.

          3. History of serious adverse effects related to anesthetics (e.g. allergic reactions), a
             family history of reactions to the study drugs.

          4. Pregnancy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohamed A Bakr, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nagwa m osman, Asst.prof.</last_name>
    <role>Study Director</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Assiut university hospital</name>
      <address>
        <city>Assiut</city>
        <zip>11111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamed A Bakr, Prof.</last_name>
      <phone>+201098983009</phone>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 16, 2015</study_first_submitted>
  <study_first_submitted_qc>November 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 1, 2015</study_first_posted>
  <last_update_submitted>July 31, 2017</last_update_submitted>
  <last_update_submitted_qc>July 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>momen mostfa youssef mekky</investigator_full_name>
    <investigator_title>resident of anesthesia and ICU, Assiut University</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
    <mesh_term>Cholangitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

